Study the correlation between plasma soluble corin and hypertention in ischemic heart disease in male patients
DOI:
https://doi.org/10.36320/ajb/v7.i2.8018Keywords:
plasma soluble corin; blood pressure; hypertension; body mass indexAbstract
The Plasma soluble corin is a key transmembrane serine protease, its principal functions is the synthesis of mature atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), these proteins have important functions in maintaining salt–water balance, blood pressure and cardiac function.
Plasma soluble corin has been suggested to be associated with hypertension and obesity by cell and animal-based studies. However, the relationship remained unclear. In the present study, an attempt is carried out to estimate the level of plasma soluble corin in ischemic heart disease (IHD) patients and compare their levels with the healthy control group in addition to the study the correlation between plasma soluble corin and hypertention and body mass index in ischemic heart disease in male patients.
One hundred and thirty six patients male patients with ischemic heart diseases including stable angina (AS), unstable angina (UA) and myocardial infarction (MI) (aged 35- >60 years) were involved in the present study during their admission to Al- Sader Teaching Hospital / Al- Najaf Al- Ashraf. Also patients groups were divided according to hypertention for the purpose of study the correlation between plasma soluble corin and this risk factor in ischemic heart disease. Body mass index, blood pressures and plasma soluble corin were determined in 176 participants aged above 35 years. Age matched forty healthy men were included as control group.
Downloads
References
Kumar, V; Abbas, AK; Fausto, N; Mitchell, RN. 2007. Robbins Basic Pathology. (8 th ed.) Philadelphia: Saunders.
American Association of Cardiovascular and Pulmonary Rehabilitation [AACVPR] (2006): American Association Cardiovascular and Pulmonary Rehabilitation Cardiac Rehabilitation Resource Manual. Leeds: Human Kinetics.
British Heart Foundation [BHF]. (2010): Cardiovascular Disease. Retrieved from the British Heart Foundation Web site: http://www.bhf.org.uk/living_with_a_heart_condition/understanding_heart_conditions/t ypes_of_heart_conditions/cardiovascular_disease.aspx.
Mullany, CJ. 2003. Coronary Bypass Surgery. Journal of the American Heart Association, 107: e21-e22. DOI: https://doi.org/10.1161/01.CIR.0000048896.72317.49
Wu, Q; Xu-Cai, YO; Chen, S; et al..2009. Corin: new insights into the natriuretic peptide system. Kidney Int ,75:142–146. DOI: https://doi.org/10.1038/ki.2008.418
Zhou, X; Chen, J; Zhang, Q; Shao, J; Du, K; Xu, X; Kong, Y. 2016. prognostic Value of Plasma Soluble Corin in Patients With Acute Myocardial Infarction. J Am Coll Cardiol, 67(17):2008-2014. DOI: https://doi.org/10.1016/j.jacc.2016.02.035
Dong, N; Chen, S; Wang, W; et al. 2012. Corin in clinical laboratory diagnostics. Clin Chim Acta, 413:378–383. DOI: https://doi.org/10.1016/j.cca.2011.10.032
Dong, N; Chen, S; Yang, J; et al. 2010. Plasma soluble corin in patients with heart failure. Circ Heart Fail, 3:207–211. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.109.903849
Rame, J E;Tam, S W; McNamara, D; et al. 2009. Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy. Circ Heart Fail , 2:541–548. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.109.866822
Peleg, A; Ghanim, D; Vered, S; et al. 2013. Serum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndrome. Eur Heart J Acute Cardiovasc Care, 2:159–165. DOI: https://doi.org/10.1177/2048872613483588
Chan, JC; Knudson, O; Wu, F; Morser, J; Dole, WP; Wu, Q. 2005. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin, Proc. Natl. Acad. Sci. U. S. A., 102 (2005) 785–790. DOI: https://doi.org/10.1073/pnas.0407234102
Gladysheva, I P; Wang, D; McNamee, R A; et al. 2013. Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy. Hypertension, 61:327–332. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.112.193631
Pang, A; Hu, Y; Zhou, P; et al. 2015. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy. Cardiovasc Diabetol , 14:134. DOI: https://doi.org/10.1186/s12933-015-0298-9
John, SW; Krege, JH; Oliver, PM et al. 1995. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science, 267: 679–681. DOI: https://doi.org/10.1126/science.7839143
Lopez, MJ; Wong, SK; Kishimoto, I et al. 1995. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature, 378: 65–68. DOI: https://doi.org/10.1038/378065a0
Nakayama, T; Soma, M; Takahashi, Y et al. 2000. Functional deletion mutation of the 50-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res, 86: 841–845. DOI: https://doi.org/10.1161/01.RES.86.8.841
Rubattu, S; Bigatti, G; Evangelista, A et al. 2006. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol, 48: 499–505. DOI: https://doi.org/10.1016/j.jacc.2005.12.081
Dries, DL; Victor, RG; Rame, JE et al. 2005. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation, 112: 2403–2410. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.568881
Rame, JE; Drazner, MH; Post, W et al. 2007. Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Hypertension, 49: 857–864. DOI: https://doi.org/10.1161/01.HYP.0000258566.95867.9e
Burnett, Jr JC; Olson, TM. 2007. Natriuretic peptides and myocardial structure: insights from population genetics. Hypertension, 49: 765–766. DOI: https://doi.org/10.1161/01.HYP.0000258567.67263.96
Molkentin, JD. 2003. A friend within the heart: natriuretic peptide receptor signaling. J Clin Invest, 111: 1275–1277. DOI: https://doi.org/10.1172/JCI18389
Wang, W; Liao, X; Fukuda, K; Knappe, S; Wu, F; Dries, DL; et al. 2008. Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ Res., 103:502–8. DOI: https://doi.org/10.1161/CIRCRESAHA.108.177352
Wang, W; Cui, Y; Shen, J; Jiang, J; Chen, S; Peng, J; et al. 2012. Saltsensitive hypertension and cardiac hypertrophy in transgenic mice expressing a corin variant identified in blacks. Hypertension., 60:1352–8. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.112.201244
Zhou, Y and Wu, Q. 2014. Corin in Natriuretic Peptide Processing and Hypertension. Curr Hypertens Rep 16:415. DOI: https://doi.org/10.1007/s11906-013-0415-7
Peng, H; Zhang, Q; Shen, H; Liu, Y; Chao, X; Tian, H; Cai, X; Jin, J. 2015. Association Between Serum Soluble Corin and Obesity in Chinese Adults: A Cross-Sectional Study. Obesity, 23(4): 856-861. DOI: https://doi.org/10.1002/oby.21016
Spiegelman, BM; Flier, JS. 2001. Obesity and the regulation of energy balance. Cell, 104:531-543. DOI: https://doi.org/10.1016/S0092-8674(01)00240-9
Mayfield, JA1; Fiebig, A; Johnstone, SE; Preuss, D. 2001. Gene families from the Arabidopsis thaliana pollen coat proteome. Science, Jun 29;292(5526):2482-5. DOI: https://doi.org/10.1126/science.1060972
Yan W; Sheng N; Seto M; Morser J; Wu Q. 1999. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart, J. Biol. Chem, 274:14926–14935. DOI: https://doi.org/10.1074/jbc.274.21.14926
Enshell-Seijffers, D; Lindon, C; Morgan, BA. 2008. The serine protease Corin is a novel modifier of the Agouti pathway. Development, 135:217-225. DOI: https://doi.org/10.1242/dev.011031
Shrestha, K; Troughton, RW; Borowski, AG; Yandle, TG; Richards, AM; Klein, AL; et al. 2010. Plasma corin levels provide minimal prognostic utility incremental to natriuretic peptides in chronic systolic heart failure. J Card Fail, 16:621-627. DOI: https://doi.org/10.1016/j.cardfail.2010.03.010
Jiang, J; Wu, S; Wang, W; Chen, S; Peng, J; Zhang, X; et al. 2011. Ectodomain shedding and autocleavage of the cardiac membrane protease corin. J Biol Chem, 286: 10066-10072. DOI: https://doi.org/10.1074/jbc.M110.185082
Knappe, S; Wu, F; Masikat, MR; Morser, J; Wu, Q. 2003. Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin. J Biol Chem, 278:52363-52370. DOI: https://doi.org/10.1074/jbc.M309991200
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Suaad M. J. Al-Hadrawy, Reham L. Al-Khaqany
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
